Metoclopramide Pilot Trial

Summary

Infants with gastroschisis typically have poor intestinal motility for the first weeks to months after birth. Prokinetic agents are often used in these infants to improve intestinal motility in an attempt to quicken the attainment of enteric feeds. However, the evidence to support this practice remains weak. Investigators hypothesize that a prokinetic agent given intravenously (infused into a vein) may be effective in improving gut motility in children with gastroschisis.

Timeline

Start

2014-03

Primary completion

2019-12-12

Completion

2019-12-12

Outcome

Outcome not reported

Stopped (Enrollment): “Decision to prematurely close the trial was made because of poor recruitment.”

Drugs

Indications